ES2111755T3 - Combinaciones antiviricas. - Google Patents

Combinaciones antiviricas.

Info

Publication number
ES2111755T3
ES2111755T3 ES93915909T ES93915909T ES2111755T3 ES 2111755 T3 ES2111755 T3 ES 2111755T3 ES 93915909 T ES93915909 T ES 93915909T ES 93915909 T ES93915909 T ES 93915909T ES 2111755 T3 ES2111755 T3 ES 2111755T3
Authority
ES
Spain
Prior art keywords
combinations
antiviric
hydroximetile
dipirid
ina
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93915909T
Other languages
English (en)
Inventor
Janet Mary Cameron
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Application granted granted Critical
Publication of ES2111755T3 publication Critical patent/ES2111755T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)

Abstract

SE DESCRIBEN COMBINACIONES DE (2R, CIS) (2 HIDROXIMETILO INA MISMAS Y 11 CICLOPROPILO DIPIRIDO [3,3 B; 21, 31 DO DEL MISMO ACEPTABLE FARMACEUTICAMENTE, FORMULACIONES FARMACEUTICAS DE TALES COMBINACIONES Y EL USO DE TALES COMBINACIONES Y FORMULACIONES PARA EL TRATAMIENTO DE INFECCIONES VIRALES, EN PARTICULAR, INFECCIONES HIV.
ES93915909T 1992-07-16 1993-07-13 Combinaciones antiviricas. Expired - Lifetime ES2111755T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929215178A GB9215178D0 (en) 1992-07-16 1992-07-16 Antiviral combinations

Publications (1)

Publication Number Publication Date
ES2111755T3 true ES2111755T3 (es) 1998-03-16

Family

ID=10718844

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93915909T Expired - Lifetime ES2111755T3 (es) 1992-07-16 1993-07-13 Combinaciones antiviricas.

Country Status (12)

Country Link
US (1) US5612333A (es)
EP (1) EP0650363B1 (es)
JP (1) JPH07508998A (es)
AT (1) ATE162401T1 (es)
AU (1) AU672022B2 (es)
CA (1) CA2140238C (es)
DE (1) DE69316621T2 (es)
DK (1) DK0650363T3 (es)
ES (1) ES2111755T3 (es)
GB (1) GB9215178D0 (es)
GR (1) GR3026141T3 (es)
WO (1) WO1994002155A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9503850D0 (en) * 1995-02-25 1995-04-19 Glaxo Group Ltd Medicaments
US7713739B1 (en) 2000-11-17 2010-05-11 Novartis Vaccines And Diagnostics, Inc. Microparticle-based transfection and activation of dendritic cells

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2660917B1 (fr) * 1990-04-11 1992-11-20 Perrier Rene Pince de prehension et machine de traitement d'objets, notamment de bouteilles, ainsi equipee.
GB9009861D0 (en) * 1990-05-02 1990-06-27 Glaxo Group Ltd Chemical compounds
AU1775592A (en) * 1991-04-03 1992-11-02 Richardson-Vicks Inc. Stabilized emulsion compositions for imparting an artificial tan to human skin
WO1992020344A1 (en) * 1991-05-16 1992-11-26 Glaxo Group Limited Antiviral combinations containing nucleoside analogs

Also Published As

Publication number Publication date
AU4568993A (en) 1994-02-14
AU672022B2 (en) 1996-09-19
ATE162401T1 (de) 1998-02-15
CA2140238C (en) 2004-04-20
EP0650363B1 (en) 1998-01-21
JPH07508998A (ja) 1995-10-05
DE69316621D1 (de) 1998-02-26
US5612333A (en) 1997-03-18
CA2140238A1 (en) 1994-02-03
DK0650363T3 (da) 1998-09-21
DE69316621T2 (de) 1998-05-07
GR3026141T3 (en) 1998-05-29
EP0650363A1 (en) 1995-05-03
WO1994002155A1 (en) 1994-02-03
GB9215178D0 (en) 1992-08-26

Similar Documents

Publication Publication Date Title
IL101145A0 (en) Pharmaceutical compositions containing synergistic combinations of nucleoside derivatives
ES2186667T3 (es) Analogos de nucleosidos de 1,3-oxatiolano.
MX9200361A (es) Nuevo uso del antagonista de adenosina.
IL102310A (en) Pharmaceutical compositions comprising cyclosporins
ATE269321T1 (de) Arzneimittel gegen virale erkrankungen
ES8801303A1 (es) Un procedimiento para preparar una formulacion farmaceutica que contiene un 2'3'-didesoxi-nucleosido.
ATE270557T1 (de) Hochkonzentrierte, lyophilisierte und flüssige faktor-ix formulierungen
ES2179193T3 (es) Combinaciones sinergicas de zidovudina, 1592u89 y 3tc.
FR2757520B1 (fr) Derive de cyclosporine, sa preparation et les compositions pharmaceutiques qui le contiennent
EP0296573A3 (en) Novel nucleosides, their preparation and pharmaceutical novel nucleosides, their preparation and pharmaceutical compositions compositions
CA2143204A1 (en) Use of Dideoxy Nucleoside Analogues in the Treatment of Viral Infections
CA2068871A1 (en) Non-glycosylated fgf-4 and compositions containing the same
CA2088600A1 (en) Herpes simplex virus vp16 vaccines
FR2706469B1 (fr) Polyisobutènes polyfonctionnels, leur préparation, leur formulation et leur utilisation.
ES2133152T3 (es) Composicion de tiotepa liofilizada estable.
ES2111755T3 (es) Combinaciones antiviricas.
IT8423517A0 (it) Composizione farmaceutica per combattere infezioni virali, eprocedimento di uso per le infezioni virali.
ES2193007T1 (es) Formulacion farmaceutica estable que comprende la modificacion ii de torsemida.
EP0227604A3 (en) Use of oligopeptides in the treatment of viral infections
ITRM950273A0 (it) Antagonisti di interluchina-6 umana del tutto incapaci di formare un legame con gp 130, e loro uso per la preparazione di composizioni farmaceutiche.
AU6206486A (en) P-acylaminobenzamides
IT9048066A0 (it) 2- amminotetraline-6, 7-sostituite attive come immunomodulanti e composizioni farmaceutiche che le contengono.
MX9203274A (es) Benzazepinas condensadas, composiciones de las mismas y uso medicinal de estas.
AP9801307A0 (en) Use of 3-amino-4-hydroxbenzoic acid for treatment of retroviral infections.
ITBO930460A1 (it) Procedimento per preparare forme farmaceutiche a rilascio controllato del principio attivo e le forme farmaceutiche cosi' ottenute.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 650363

Country of ref document: ES